凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002821 凯莱英

已收盘 02-11 15:00:00

{"stockData":{"symbol":"002821","market":"SZ","secType":"STK","nameCN":"凯莱英","latestPrice":103.82,"timestamp":1770793386000,"preClose":104.8,"halted":0,"volume":1974449,"delay":0,"changeRate":-0.0094,"floatShares":317000000,"shares":361000000,"eps":2.8788,"marketStatus":"已收盘","change":-0.98,"latestTime":"02-11 15:00:00","open":105.01,"high":105.44,"low":103.57,"amount":206000000,"amplitude":0.0178,"askPrice":103.85,"askSize":3,"bidPrice":103.82,"bidSize":5,"shortable":0,"etf":0,"ttmEps":2.8788,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770859800000},"marketStatusCode":5,"adr":0,"adjPreClose":104.8,"symbolType":"stock","openAndCloseTimeList":[[1770773400000,1770780600000],[1770786000000,1770793200000]],"highLimit":115.28,"lowLimit":94.32,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":360874970,"isCdr":false,"pbRate":2.18,"roa":"--","peRate":36.063638,"roe":"4.63%","epsLYR":2.69,"committee":0.071429,"marketValue":37466000000,"turnoverRate":0.0062,"status":1,"hkstockBrief":{"symbol":"06821","market":"HK","secType":"STK","nameCN":"凯莱英","latestPrice":85.85,"timestamp":1770797293005,"preClose":88.15,"halted":0,"volume":211400,"delay":0,"premium":"-26.88"},"floatMarketCap":32911000000},"requestUrl":"/m/hq/s/002821/tweets","defaultTab":"tweets","newsList":[{"id":"2610634376","title":"小摩增持凯莱英(06821)4700股 每股作价80.6776港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610634376","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610634376?lang=zh_cn&edition=full","pubTime":"2026-02-09 19:04","pubTimestamp":1770635051,"startTime":"0","endTime":"0","summary":"增持后最新持股数目约为167.27万股，最新持股比例为6%。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260209/20260209190438_74749.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260209/20260209190438_74749.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403274.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU2456880835.USD","BK4581","BK4504","LU0149725797.USD","LU1032466523.USD","BK4534","BK0239","LU1244550577.SGD","LU0234572021.USD","LU0211327993.USD","LU0345770993.USD","BK4207","LU0323591593.USD","LU1894683264.USD","LU2237443382.USD","LU2505996681.GBP","LU2756315664.SGD","LU0820561909.HKD","IE00B1BXHZ80.USD","LU2756315318.SGD","IE00BJTD4V19.USD","LU2237443622.USD","BK0132","LU2746668974.SGD","LU1551013425.SGD","LU2023250330.USD","IE00B1XK9C88.USD","LU0787776722.HKD","LU1145028129.USD","IE00BDCRKT87.USD","LU1914381329.SGD","LU1894683348.USD","LU2264538146.SGD","LU0265550359.USD","LU1328615791.USD","LU1917777945.USD","LU0496365809.HKD","002821","BK4585","06821","LU0208291251.USD","LU2462157665.USD","IE00BLSP4452.SGD","LU0882574139.USD","SG9999002232.USD","IE00BLSP4239.USD","LU1670627923.USD","LU0964807845.USD","IE0034235188.USD","IE00B775SV38.USD"],"gpt_icon":0},{"id":"2609967665","title":"Norges Bank增持凯莱英(06821)5.35万股 每股作价约79.01港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609967665","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609967665?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:11","pubTimestamp":1770383491,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，2月3日，Norges Bank增持凯莱英(06821)5.35万股，每股作价79.0068港元，总金额约为422.69万港元。增持后最新持股数目为450.65万股，最新持股比例为16.19%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402777.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","06821","BK0239","002821","BK0132","LU1328615791.USD"],"gpt_icon":0},{"id":"2609967595","title":"摩根大通减持凯莱英(06821)1.98万股 每股作价约78.64港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609967595","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609967595?lang=zh_cn&edition=full","pubTime":"2026-02-06 21:10","pubTimestamp":1770383420,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，2月3日，摩根大通减持凯莱英(06821)1.98万股，每股作价78.6378港元，总金额约为155.7万港元。减持后最新持股数目约为166.8万股，持股比例为5.99%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1402775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0267386448.USD","LU0417517546.SGD","LU1267930490.SGD","IE0034235295.USD","LU2430703178.SGD","LU0868494617.USD","LU0149725797.USD","BK4581","LU2023250504.SGD","LU0787776722.HKD","LU2054465674.USD","LU0976567544.SGD","IE00B3S45H60.SGD","LU0211328371.USD","LU1551013342.USD","LU1162221912.USD","LU0971096721.USD","06821","LU1988902786.USD","LU2106854487.HKD","IE00BWXC8680.SGD","LU1720051017.SGD","LU0048584097.USD","LU1894683348.USD","LU2242649171.HKD","LU2430703095.HKD","IE00BJTD4N35.SGD","LU0203345920.USD","LU0496365809.HKD","IE00BZ1G4Q59.USD","SG9999002232.USD","LU0265550359.USD","BK4585","LU0345770308.USD","IE00BYXW3230.USD","LU0942090050.USD","LU2237443549.SGD","LU2417539215.USD","LU1548497426.USD","IE000M9KFDE8.USD","BK4516","LU0320765646.SGD","LU0683600562.USD","LU2552382058.USD","002821","LU2381873111.SGD","LU2456880835.USD","LU0345770993.USD","LU0265550946.USD","IE00B1XK9C88.USD"],"gpt_icon":0},{"id":"2608827060","title":"摩根大通减持凯莱英(06821)0.78万股 每股作价约80.84港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608827060","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608827060?lang=zh_cn&edition=full","pubTime":"2026-02-03 18:59","pubTimestamp":1770116376,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新数据显示，1月28日，摩根大通减持凯莱英(06821)0.78万股，每股作价80.8366港元，总金额约为63.05万港元。减持后最新持股数目约为166.27万股，持股比例为5.97%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1401152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0820561909.HKD","IE00BKDWB100.SGD","06821","LU2505996681.GBP","LU0323591593.USD","IE00BLSP4452.SGD","LU0267386448.USD","LU1116320901.HKD","LU1363072403.SGD","LU0265550359.USD","LU1974910355.USD","IE00B3S45H60.SGD","LU1267930490.SGD","LU1548497426.USD","LU1917777945.USD","LU1328615791.USD","LU2211815571.USD","BK0132","LU0215105999.USD","LU2236285917.USD","BK1191","LU0170899867.USD","SG9999002224.SGD","IE00BKVL7J92.USD","LU1119994496.HKD","LU0964807845.USD","LU0820561818.USD","LU1261432733.SGD","LU0238689110.USD","LU1064131342.USD","LU0070302665.USD","LU0310799852.SGD","002821","LU0943347566.SGD","BK4550","BK0239","LU2417539215.USD","BK4533","LU2213496289.HKD","LU1894683348.USD","LU1551013342.USD","LU2237443465.HKD","IE00BJTD4V19.USD","LU2505996509.AUD","SG9999002232.USD","IE00B1BXHZ80.USD","BK4588","IE00BJTD4N35.SGD","LU2237443382.USD","LU0211326839.USD"],"gpt_icon":0},{"id":"2607085321","title":"Norges Bank增持凯莱英(06821)9.97万股 每股作价约80.67港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607085321","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607085321?lang=zh_cn&edition=full","pubTime":"2026-01-29 18:53","pubTimestamp":1769684007,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月28日，Norges Bank增持凯莱英(06821)9.97万股，每股作价80.6683港元，总金额约为804.26万港元。增持后最新持股数目为423.53万股，最新持股比例为15.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","06821","BK1191","BK0132","002821","LU1328615791.USD"],"gpt_icon":0},{"id":"2606436842","title":"凯莱英(06821)根据H股限制性股票计划发行28.13万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2606436842","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606436842?lang=zh_cn&edition=full","pubTime":"2026-01-26 21:21","pubTimestamp":1769433672,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯莱英(06821)发布公告，该公司于2026年1月26日根据H股限制性股票计划向受托人发行并配发股份28.13万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397585.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002821","LU1328615791.USD","BK1191","06821","BK0132","BK0239"],"gpt_icon":0},{"id":"2605281276","title":"凯莱英公布国际专利申请：“一种Patisiran的制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2605281276","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605281276?lang=zh_cn&edition=full","pubTime":"2026-01-24 08:50","pubTimestamp":1769215845,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示凯莱英（002821）公布了一项国际专利申请，专利名为“一种Patisiran的制备方法”，专利申请号为PCT/CN2025/079387，国际公布日为2026年1月15日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来凯莱英已公布的国际专利申请12个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了2.86亿元，同比减13.06%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012400011772.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK1191","LU1328615791.USD","06821","002821","BK0239"],"gpt_icon":0},{"id":"2605817532","title":"凯莱英公布国际专利申请：“治疗α1-抗胰蛋白酶缺乏症的siRNA的制备方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2605817532","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605817532?lang=zh_cn&edition=full","pubTime":"2026-01-24 08:50","pubTimestamp":1769215841,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示凯莱英（002821）公布了一项国际专利申请，专利名为“治疗α1-抗胰蛋白酶缺乏症的siRNA的制备方法”，专利申请号为PCT/CN2025/079380，国际公布日为2026年1月15日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来凯莱英已公布的国际专利申请12个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了2.86亿元，同比减13.06%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012400011740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","002821","06821","BK0239","BK0132","BK1191"],"gpt_icon":0},{"id":"2605281743","title":"凯莱英公布国际专利申请：“可溶性表达质粒突变体库的构建方法及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2605281743","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605281743?lang=zh_cn&edition=full","pubTime":"2026-01-24 08:50","pubTimestamp":1769215839,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示凯莱英（002821）公布了一项国际专利申请，专利名为“可溶性表达质粒突变体库的构建方法及其应用”，专利申请号为PCT/CN2025/071619，国际公布日为2026年1月15日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来凯莱英已公布的国际专利申请12个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了2.86亿元，同比减13.06%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012400011726.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK0132","LU1328615791.USD","002821","06821"],"gpt_icon":0},{"id":"2605439034","title":"申庆2025年四季度表现，兴全沪深300指数增强(LOF)Y基金季度涨幅2.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605439034","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605439034?lang=zh_cn&edition=full","pubTime":"2026-01-22 07:10","pubTimestamp":1769037005,"startTime":"0","endTime":"0","summary":"证券之星消息，截止2025年四季度末，基金经理申庆旗下共管理3只基金，本季度表现最佳的为兴全沪深300指数增强Y，季度净值涨2.69%。申庆在担任兴全沪深300指数A基金经理的任职期间累计任职回报180.51%，平均年化收益率为7.01%。持有期间的估算收益率为530.35%，持有期间凯莱英在2017年到2021年的年报营业总收入增幅达225.98%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200004315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["510300","399001","002044","300353","399006","512880","000300.SH","000905.SH","512510","000688.SH","159967","06821","515890","002821","510880"],"gpt_icon":0},{"id":"2605849344","title":"股市必读：凯莱英（002821）1月21日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2605849344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605849344?lang=zh_cn&edition=full","pubTime":"2026-01-22 01:29","pubTimestamp":1769016548,"startTime":"0","endTime":"0","summary":"截至2026年1月21日收盘，凯莱英报收于103.8元，上涨0.58%，换手率1.23%，成交量3.91万手，成交额4.09亿元。董秘最新回复投资者： 贵司小分子PPQ项目的减少，是否意味着小分子商业化项目的减少？当日关注点来自交易信息汇总：1月21日主力资金净流入1747.64万元，呈现明显吸筹迹象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200000610.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","06821","BK0239","002821","BK0132","LU1328615791.USD"],"gpt_icon":0},{"id":"2604013818","title":"Norges Bank减持凯莱英(06821)11万股 每股作价约88.2港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604013818","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604013818?lang=zh_cn&edition=full","pubTime":"2026-01-19 19:08","pubTimestamp":1768820899,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月14日，Norges Bank减持凯莱英(06821)11万股，每股作价88.1971港元，总金额约为970.17万港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260119/20260119190838_98807.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260119/20260119190838_98807.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1394640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06821","002821","BK0239","BK0132","LU1328615791.USD","BK1191"],"gpt_icon":0},{"id":"2604597901","title":"股市必读：凯莱英（002821）1月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2604597901","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604597901?lang=zh_cn&edition=full","pubTime":"2026-01-19 01:28","pubTimestamp":1768757289,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，凯莱英报收于107.33元，上涨0.78%，换手率1.88%，成交量5.97万手，成交额6.39亿元。公司所服务的PPQ项目数量会随着公司所服务的项目进展，比如获批上市等情况动态变化。当日关注点来自交易信息汇总：1月16日主力资金净流出4067.55万元，游资资金净流入4069.08万元，呈现主力与游资反向操作态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900000525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","002821","LU1328615791.USD","BK0132","BK1191","BK0239"],"gpt_icon":0},{"id":"2603688509","title":"Schroders PLC减持凯莱英(06821)16.77万股 每股作价约83.63港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603688509","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603688509?lang=zh_cn&edition=full","pubTime":"2026-01-13 18:53","pubTimestamp":1768301597,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，1月9日，Schroders PLC减持凯莱英(06821)16.77万股，每股作价83.6305港元，总金额约为1402.48万港元。减持后最新持股数目为550.56万股，最新持股比例为19.98%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392307.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","LU1328615791.USD","BK0239","BK0132","002821","06821"],"gpt_icon":0},{"id":"2602553587","title":"凯莱英遭Schroders PLC减持26.05万股 每股作价约82.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602553587","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602553587?lang=zh_cn&edition=full","pubTime":"2026-01-11 16:29","pubTimestamp":1768120140,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　香港联交所最新资料显示，1月7日，Schroders PLC减持凯莱英（06821）26.05万股，每股作价82.7099港元，总金额约为2154.59万港元。减持后最新持股数目为574.18万股，最新持股比例为20.84%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-11/doc-inhfxmcp3825365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1328615791.USD","BK0132","BK0239","BK1191","002821","06821"],"gpt_icon":0},{"id":"2602378543","title":"Schroders PLC减持凯莱英(06821)26.05万股 每股作价约82.71港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602378543","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602378543?lang=zh_cn&edition=full","pubTime":"2026-01-09 19:30","pubTimestamp":1767958245,"startTime":"0","endTime":"0","summary":"香港联交所最新资料显示，1月7日，Schroders PLC减持凯莱英(06821)26.05万股，每股作价82.7099港元，总金额约为2154.59万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260109/20260109193119_38417.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260109/20260109193119_38417.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["06821","002821","LU1328615791.USD","BK0132","BK1191","BK0239"],"gpt_icon":0},{"id":"2601880356","title":"凯莱英（002821）披露证券变动月报表，1月5日股价上涨3.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601880356","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601880356?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:45","pubTimestamp":1767624323,"startTime":"0","endTime":"0","summary":"截至2026年1月5日收盘，凯莱英报收于95.88元，较前一交易日上涨3.17%，最新总市值为345.74亿元。该股当日开盘93.2元，最高96.88元，最低93.04元，成交额达5.58亿元，换手率为1.84%。近日，凯莱英发布H股证券变动月报表公告。公告显示，截至2025年12月31日，公司H股和A股的法定/注册股本均无变动。H股已发行股份为27,553,260股，A股已发行股份为331,889,160股，库存股为1,151,300股。H股限制性股票计划项下本月底可能发行的股份为1,465,000股。公司呈交日期为2026年1月5日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500040546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","BK1191","06821","BK0132","002821","BK0239","161027"],"gpt_icon":0},{"id":"2595972714","title":"凯莱英：多肽项目进入中后期后对产能需求高","url":"https://stock-news.laohu8.com/highlight/detail?id=2595972714","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595972714?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:15","pubTimestamp":1767172517,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英(002821)12月31日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司多肽产能不断扩建已经要达到4万升了，但是贵司服务的核心多肽产品玛仕度肽订单被诺泰生物抢走了一些，贵司的多肽产能是否会面临着闲置的风险？凯莱英回复：尊敬的投资者，您好！多肽项目进入中后期后对产能需求高，目前公司在多肽减重领域共服务十几个分子， 近半数处于临床Ⅱ和Ⅲ期，预计明年部分项目将进入PPQ阶段，产能需求持续增加。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100030708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1328615791.USD","BK1191","BK0239","06821","BK0132","002821"],"gpt_icon":0},{"id":"2595727110","title":"凯莱英：天津新产能匹配新业务领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2595727110","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595727110?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:15","pubTimestamp":1767172517,"startTime":"0","endTime":"0","summary":"证券之星消息，凯莱英(002821)12月31日在投资者关系平台上答复投资者关心的问题。投资者提问：贵司天津小分子产能紧张，为何不能分流业务到敦化小分子基地生产？本来公司产能就闲置，为何还要重复建设产能？凯莱英回复：尊敬的投资者，您好！公司需要根据项目整体情况不同匹配最佳产能，以达到效益最大化。天津新产能主要匹配增速较快的新业务领域。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100030707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06821","LU1328615791.USD","002821","BK0132","BK0239","BK1191"],"gpt_icon":0},{"id":"2594521497","title":"深市“双提升”：471家率先行动，分红占净利润比重2年提升近11个百分点","url":"https://stock-news.laohu8.com/highlight/detail?id=2594521497","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594521497?lang=zh_cn&edition=full","pubTime":"2025-12-27 11:01","pubTimestamp":1766804460,"startTime":"0","endTime":"0","summary":"　　已有471家深市公司披露行动方案。　　去年2月，深交所正式启动“质量回报双提升”专项行动，旨在推动全体上市公司夯实发展质量、增强投资价值回报能力。　　市场反应积极正面，2024年2月至2025年11月，471家“双提升”公司股价平均涨幅77.2%，高于深证成指涨幅。截至2025年11月底，市值合计21.2万亿元，较专项行动启动前增长8.1万亿元，占深市总市值比重50.0%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-27/doc-inheezwv0075071.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-27/doc-inheezwv0075071.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1655091616.SGD","301095","LU0633140727.USD","BK0070","LU2348774022.SGD","LU2153592121.USD","300919","BK0187","LU0594300419.USD","LU0469268626.HKD","002241","LU2289578879.USD","BK0196","BK0188","LU1242518857.USD","BK0132","000725","LU0405327148.USD","IE00B031J352.USD","LU2495084118.USD","LU1997245094.SGD","BK0060","BK0251","300122","LU2148510915.USD","LU1734074674.USD","IE00B29SXG58.USD","BK0046","SGXZ49509284.SGD","LU2663582299.SGD","EVS.SI","LU1508157978.USD","002821","002594","IE0008368742.USD","BK0109","LU0823426480.USD","LU1969619763.USD","300760","300476","BK0231","LU1861214812.USD","LU0650527681.SGD","002493","BK0197","LU1328615791.USD","LU1064130708.USD","300009","LU2348773727.SGD","LU2580892789.USD"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1770828811056,"stockEarnings":[{"period":"1week","weight":0.038},{"period":"1month","weight":-0.0064},{"period":"3month","weight":0.0793},{"period":"6month","weight":-0.0484},{"period":"1year","weight":0.2841},{"period":"ytd","weight":0.1172}],"compareEarnings":[{"period":"1week","weight":0.0073},{"period":"1month","weight":-0.008},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1177},{"period":"1year","weight":0.2453},{"period":"ytd","weight":0.0411}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"凯莱英医药集团(天津)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2016-11-18","address":"天津市滨海新区经济技术开发区洞庭三街6号","registeredCapital":"36087万元","survey":"　　凯莱英医药集团(天津)股份有限公司的主营业务是为国内外制药公司、生物技术公司提供药品全生命周期的一站式服务。公司的主要产品是临床阶段CDMO解决方案、商业化阶段CDMO解决方案、新兴服务。截至报告期末公司共有国内外已授权专利538项，其中国内专利423项，国外专利115项，其中183项在合成生物领域，204项在连续反应技术领域。","listedPrice":30.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯莱英,002821,凯莱英股票,凯莱英股票老虎,凯莱英股票老虎国际,凯莱英行情,凯莱英股票行情,凯莱英股价,凯莱英股市,凯莱英股票价格,凯莱英股票交易,凯莱英股票购买,凯莱英股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯莱英(002821)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯莱英(002821)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}